nodes	percent_of_prediction	percent_of_DWPC	metapath
Fluticasone furoate—ABCB1—lung cancer	0.313	1	CbGaD
Fluticasone furoate—ABCB1—Topotecan—lung cancer	0.045	0.0864	CbGbCtD
Fluticasone furoate—ABCB1—Gefitinib—lung cancer	0.0411	0.079	CbGbCtD
Fluticasone furoate—ABCB1—Vinorelbine—lung cancer	0.0317	0.0609	CbGbCtD
Fluticasone furoate—CYP3A4—Topotecan—lung cancer	0.0269	0.0518	CbGbCtD
Fluticasone furoate—ABCB1—Crizotinib—lung cancer	0.0252	0.0484	CbGbCtD
Fluticasone furoate—CYP3A4—Gefitinib—lung cancer	0.0246	0.0473	CbGbCtD
Fluticasone furoate—ABCB1—Gemcitabine—lung cancer	0.0246	0.0473	CbGbCtD
Fluticasone furoate—ABCB1—Erlotinib—lung cancer	0.0243	0.0467	CbGbCtD
Fluticasone furoate—CYP3A4—Teniposide—lung cancer	0.0239	0.0459	CbGbCtD
Fluticasone furoate—ABCB1—Paclitaxel—lung cancer	0.0223	0.0428	CbGbCtD
Fluticasone furoate—ABCB1—Irinotecan—lung cancer	0.022	0.0422	CbGbCtD
Fluticasone furoate—ABCB1—Vinblastine—lung cancer	0.0195	0.0375	CbGbCtD
Fluticasone furoate—CYP3A4—Vinorelbine—lung cancer	0.019	0.0365	CbGbCtD
Fluticasone furoate—ABCB1—Cisplatin—lung cancer	0.0179	0.0344	CbGbCtD
Fluticasone furoate—ABCB1—Etoposide—lung cancer	0.0176	0.0338	CbGbCtD
Fluticasone furoate—ABCB1—Docetaxel—lung cancer	0.0161	0.0309	CbGbCtD
Fluticasone furoate—CYP3A4—Crizotinib—lung cancer	0.0151	0.029	CbGbCtD
Fluticasone furoate—CYP3A4—Erlotinib—lung cancer	0.0146	0.028	CbGbCtD
Fluticasone furoate—CYP3A4—Paclitaxel—lung cancer	0.0133	0.0256	CbGbCtD
Fluticasone furoate—CYP3A4—Irinotecan—lung cancer	0.0132	0.0253	CbGbCtD
Fluticasone furoate—ABCB1—Doxorubicin—lung cancer	0.012	0.023	CbGbCtD
Fluticasone furoate—CYP3A4—Vinblastine—lung cancer	0.0117	0.0225	CbGbCtD
Fluticasone furoate—ABCB1—Methotrexate—lung cancer	0.0116	0.0223	CbGbCtD
Fluticasone furoate—CYP3A4—Etoposide—lung cancer	0.0105	0.0202	CbGbCtD
Fluticasone furoate—CYP3A4—Docetaxel—lung cancer	0.00964	0.0185	CbGbCtD
Fluticasone furoate—CYP3A4—Doxorubicin—lung cancer	0.00719	0.0138	CbGbCtD
Fluticasone furoate—Amcinonide—ANXA1—lung cancer	0.00178	0.473	CrCbGaD
Fluticasone furoate—Dexamethasone—ANXA1—lung cancer	0.000558	0.149	CrCbGaD
Fluticasone furoate—Dermatitis—Crizotinib—lung cancer	0.000421	0.00385	CcSEcCtD
Fluticasone furoate—Diarrhoea—Pemetrexed—lung cancer	0.000418	0.00382	CcSEcCtD
Fluticasone furoate—Diarrhoea—Gefitinib—lung cancer	0.000415	0.0038	CcSEcCtD
Fluticasone furoate—Angioedema—Topotecan—lung cancer	0.000411	0.00375	CcSEcCtD
Fluticasone furoate—Dizziness—Pemetrexed—lung cancer	0.000404	0.00369	CcSEcCtD
Fluticasone furoate—Immune system disorder—Vinorelbine—lung cancer	0.000399	0.00365	CcSEcCtD
Fluticasone furoate—Mediastinal disorder—Vinorelbine—lung cancer	0.000398	0.00364	CcSEcCtD
Fluticasone furoate—Nausea—Crizotinib—lung cancer	0.000397	0.00363	CcSEcCtD
Fluticasone furoate—Urticaria—Teniposide—lung cancer	0.000393	0.00359	CcSEcCtD
Fluticasone furoate—Cough—Topotecan—lung cancer	0.000392	0.00358	CcSEcCtD
Fluticasone furoate—Herpes simplex—Methotrexate—lung cancer	0.000392	0.00358	CcSEcCtD
Fluticasone furoate—Body temperature increased—Teniposide—lung cancer	0.000391	0.00358	CcSEcCtD
Fluticasone furoate—Cough—Erlotinib—lung cancer	0.000388	0.00355	CcSEcCtD
Fluticasone furoate—Rash—Pemetrexed—lung cancer	0.000385	0.00352	CcSEcCtD
Fluticasone furoate—Dermatitis—Pemetrexed—lung cancer	0.000385	0.00352	CcSEcCtD
Fluticasone furoate—Visual disturbance—Docetaxel—lung cancer	0.000384	0.00351	CcSEcCtD
Fluticasone furoate—Nasopharyngitis—Paclitaxel—lung cancer	0.000384	0.00351	CcSEcCtD
Fluticasone furoate—Rash—Gefitinib—lung cancer	0.000383	0.0035	CcSEcCtD
Fluticasone furoate—Dermatitis—Gefitinib—lung cancer	0.000382	0.0035	CcSEcCtD
Fluticasone furoate—Ulcer—Methotrexate—lung cancer	0.000382	0.00349	CcSEcCtD
Fluticasone furoate—Dysphonia—Doxorubicin—lung cancer	0.00038	0.00348	CcSEcCtD
Fluticasone furoate—Back pain—Vinorelbine—lung cancer	0.000372	0.0034	CcSEcCtD
Fluticasone furoate—Anaphylactic shock—Topotecan—lung cancer	0.000367	0.00335	CcSEcCtD
Fluticasone furoate—Hypersensitivity—Teniposide—lung cancer	0.000365	0.00333	CcSEcCtD
Fluticasone furoate—Infection—Topotecan—lung cancer	0.000364	0.00333	CcSEcCtD
Fluticasone furoate—Nausea—Pemetrexed—lung cancer	0.000363	0.00332	CcSEcCtD
Fluticasone furoate—Nausea—Gefitinib—lung cancer	0.000361	0.0033	CcSEcCtD
Fluticasone furoate—Infection—Erlotinib—lung cancer	0.000361	0.0033	CcSEcCtD
Fluticasone furoate—Nervous system disorder—Topotecan—lung cancer	0.00036	0.00329	CcSEcCtD
Fluticasone furoate—Migraine—Docetaxel—lung cancer	0.000358	0.00327	CcSEcCtD
Fluticasone furoate—Conjunctivitis—Cisplatin—lung cancer	0.000358	0.00327	CcSEcCtD
Fluticasone furoate—Connective tissue disorder—Irinotecan—lung cancer	0.000358	0.00327	CcSEcCtD
Fluticasone furoate—Bronchitis—Paclitaxel—lung cancer	0.000357	0.00326	CcSEcCtD
Fluticasone furoate—Nervous system disorder—Erlotinib—lung cancer	0.000356	0.00325	CcSEcCtD
Fluticasone furoate—Pharyngitis—Gemcitabine—lung cancer	0.000352	0.00322	CcSEcCtD
Fluticasone furoate—Angioedema—Vinorelbine—lung cancer	0.000351	0.00321	CcSEcCtD
Fluticasone furoate—Visual impairment—Irinotecan—lung cancer	0.000351	0.00321	CcSEcCtD
Fluticasone furoate—Connective tissue disorder—Gemcitabine—lung cancer	0.000349	0.00319	CcSEcCtD
Fluticasone furoate—Palpitations—Vinorelbine—lung cancer	0.00034	0.00311	CcSEcCtD
Fluticasone furoate—Herpes simplex—Doxorubicin—lung cancer	0.00034	0.0031	CcSEcCtD
Fluticasone furoate—Diarrhoea—Teniposide—lung cancer	0.000339	0.00309	CcSEcCtD
Fluticasone furoate—Cough—Vinorelbine—lung cancer	0.000336	0.00307	CcSEcCtD
Fluticasone furoate—Ulcer—Doxorubicin—lung cancer	0.000331	0.00302	CcSEcCtD
Fluticasone furoate—Immune system disorder—Irinotecan—lung cancer	0.000329	0.00301	CcSEcCtD
Fluticasone furoate—Mediastinal disorder—Irinotecan—lung cancer	0.000328	0.003	CcSEcCtD
Fluticasone furoate—Dyspnoea—Topotecan—lung cancer	0.000327	0.00299	CcSEcCtD
Fluticasone furoate—Nasopharyngitis—Docetaxel—lung cancer	0.000326	0.00297	CcSEcCtD
Fluticasone furoate—Connective tissue disorder—Cisplatin—lung cancer	0.000325	0.00297	CcSEcCtD
Fluticasone furoate—Dyspnoea—Erlotinib—lung cancer	0.000324	0.00296	CcSEcCtD
Fluticasone furoate—Atrioventricular block—Doxorubicin—lung cancer	0.000323	0.00295	CcSEcCtD
Fluticasone furoate—Conjunctivitis—Paclitaxel—lung cancer	0.000322	0.00294	CcSEcCtD
Fluticasone furoate—Clobetasol propionate—CYP1A1—lung cancer	0.000321	0.0853	CrCbGaD
Fluticasone furoate—Immune system disorder—Gemcitabine—lung cancer	0.000321	0.00293	CcSEcCtD
Fluticasone furoate—Mediastinal disorder—Gemcitabine—lung cancer	0.00032	0.00292	CcSEcCtD
Fluticasone furoate—Visual impairment—Cisplatin—lung cancer	0.000319	0.00291	CcSEcCtD
Fluticasone furoate—Anaphylactic shock—Vinorelbine—lung cancer	0.000314	0.00287	CcSEcCtD
Fluticasone furoate—Epistaxis—Paclitaxel—lung cancer	0.000312	0.00285	CcSEcCtD
Fluticasone furoate—Rash—Teniposide—lung cancer	0.000312	0.00285	CcSEcCtD
Fluticasone furoate—Dermatitis—Teniposide—lung cancer	0.000312	0.00285	CcSEcCtD
Fluticasone furoate—Infection—Vinorelbine—lung cancer	0.000312	0.00285	CcSEcCtD
Fluticasone furoate—Headache—Teniposide—lung cancer	0.00031	0.00283	CcSEcCtD
Fluticasone furoate—Eye disorder—Cisplatin—lung cancer	0.000309	0.00282	CcSEcCtD
Fluticasone furoate—Nervous system disorder—Vinorelbine—lung cancer	0.000308	0.00281	CcSEcCtD
Fluticasone furoate—Back pain—Irinotecan—lung cancer	0.000307	0.0028	CcSEcCtD
Fluticasone furoate—Back pain—Gemcitabine—lung cancer	0.000299	0.00273	CcSEcCtD
Fluticasone furoate—Candida infection—Doxorubicin—lung cancer	0.000299	0.00273	CcSEcCtD
Fluticasone furoate—Immune system disorder—Cisplatin—lung cancer	0.000299	0.00273	CcSEcCtD
Fluticasone furoate—Mediastinal disorder—Cisplatin—lung cancer	0.000298	0.00272	CcSEcCtD
Fluticasone furoate—Pharyngitis—Paclitaxel—lung cancer	0.000295	0.00269	CcSEcCtD
Fluticasone furoate—Nausea—Teniposide—lung cancer	0.000294	0.00269	CcSEcCtD
Fluticasone furoate—Connective tissue disorder—Paclitaxel—lung cancer	0.000292	0.00267	CcSEcCtD
Fluticasone furoate—Urticaria—Topotecan—lung cancer	0.000291	0.00266	CcSEcCtD
Fluticasone furoate—Body temperature increased—Topotecan—lung cancer	0.00029	0.00265	CcSEcCtD
Fluticasone furoate—Body temperature increased—Erlotinib—lung cancer	0.000287	0.00262	CcSEcCtD
Fluticasone furoate—Visual impairment—Paclitaxel—lung cancer	0.000286	0.00262	CcSEcCtD
Fluticasone furoate—Eye disorder—Etoposide—lung cancer	0.000283	0.00259	CcSEcCtD
Fluticasone furoate—Dyspnoea—Vinorelbine—lung cancer	0.00028	0.00256	CcSEcCtD
Fluticasone furoate—Hypersensitivity—Vinblastine—lung cancer	0.000278	0.00254	CcSEcCtD
Fluticasone furoate—Eye disorder—Paclitaxel—lung cancer	0.000278	0.00254	CcSEcCtD
Fluticasone furoate—Visual disturbance—Methotrexate—lung cancer	0.000277	0.00253	CcSEcCtD
Fluticasone furoate—Cough—Irinotecan—lung cancer	0.000277	0.00253	CcSEcCtD
Fluticasone furoate—Immune system disorder—Etoposide—lung cancer	0.000274	0.0025	CcSEcCtD
Fluticasone furoate—Mediastinal disorder—Etoposide—lung cancer	0.000273	0.0025	CcSEcCtD
Fluticasone furoate—Conjunctivitis—Docetaxel—lung cancer	0.000273	0.00249	CcSEcCtD
Fluticasone furoate—Hypersensitivity—Topotecan—lung cancer	0.00027	0.00247	CcSEcCtD
Fluticasone furoate—Tremor—Cisplatin—lung cancer	0.00027	0.00247	CcSEcCtD
Fluticasone furoate—Cough—Gemcitabine—lung cancer	0.00027	0.00246	CcSEcCtD
Fluticasone furoate—Immune system disorder—Paclitaxel—lung cancer	0.000268	0.00245	CcSEcCtD
Fluticasone furoate—Mediastinal disorder—Paclitaxel—lung cancer	0.000268	0.00245	CcSEcCtD
Fluticasone furoate—Epistaxis—Docetaxel—lung cancer	0.000265	0.00242	CcSEcCtD
Fluticasone furoate—Anaphylactic shock—Irinotecan—lung cancer	0.000259	0.00237	CcSEcCtD
Fluticasone furoate—Diarrhoea—Vinblastine—lung cancer	0.000258	0.00236	CcSEcCtD
Fluticasone furoate—Infection—Irinotecan—lung cancer	0.000257	0.00235	CcSEcCtD
Fluticasone furoate—Back pain—Etoposide—lung cancer	0.000255	0.00233	CcSEcCtD
Fluticasone furoate—Nervous system disorder—Irinotecan—lung cancer	0.000254	0.00232	CcSEcCtD
Fluticasone furoate—Anaphylactic shock—Gemcitabine—lung cancer	0.000252	0.0023	CcSEcCtD
Fluticasone furoate—Diarrhoea—Topotecan—lung cancer	0.000251	0.00229	CcSEcCtD
Fluticasone furoate—Infection—Gemcitabine—lung cancer	0.00025	0.00229	CcSEcCtD
Fluticasone furoate—Back pain—Paclitaxel—lung cancer	0.00025	0.00229	CcSEcCtD
Fluticasone furoate—Pharyngitis—Docetaxel—lung cancer	0.00025	0.00228	CcSEcCtD
Fluticasone furoate—Dizziness—Vinblastine—lung cancer	0.00025	0.00228	CcSEcCtD
Fluticasone furoate—Urticaria—Vinorelbine—lung cancer	0.000249	0.00228	CcSEcCtD
Fluticasone furoate—Diarrhoea—Erlotinib—lung cancer	0.000248	0.00227	CcSEcCtD
Fluticasone furoate—Body temperature increased—Vinorelbine—lung cancer	0.000248	0.00227	CcSEcCtD
Fluticasone furoate—Connective tissue disorder—Docetaxel—lung cancer	0.000247	0.00226	CcSEcCtD
Fluticasone furoate—Nervous system disorder—Gemcitabine—lung cancer	0.000247	0.00226	CcSEcCtD
Fluticasone furoate—Visual impairment—Docetaxel—lung cancer	0.000243	0.00222	CcSEcCtD
Fluticasone furoate—Dizziness—Topotecan—lung cancer	0.000243	0.00222	CcSEcCtD
Fluticasone furoate—Tremor—Paclitaxel—lung cancer	0.000242	0.00221	CcSEcCtD
Fluticasone furoate—Dizziness—Erlotinib—lung cancer	0.00024	0.00219	CcSEcCtD
Fluticasone furoate—Agitation—Paclitaxel—lung cancer	0.000238	0.00217	CcSEcCtD
Fluticasone furoate—Headache—Vinblastine—lung cancer	0.000237	0.00216	CcSEcCtD
Fluticasone furoate—Angioedema—Paclitaxel—lung cancer	0.000236	0.00216	CcSEcCtD
Fluticasone furoate—Eye disorder—Docetaxel—lung cancer	0.000235	0.00215	CcSEcCtD
Fluticasone furoate—Anaphylactic shock—Cisplatin—lung cancer	0.000235	0.00215	CcSEcCtD
Fluticasone furoate—Infection—Cisplatin—lung cancer	0.000233	0.00213	CcSEcCtD
Fluticasone furoate—Rash—Topotecan—lung cancer	0.000231	0.00211	CcSEcCtD
Fluticasone furoate—Hypersensitivity—Vinorelbine—lung cancer	0.000231	0.00211	CcSEcCtD
Fluticasone furoate—Dermatitis—Topotecan—lung cancer	0.000231	0.00211	CcSEcCtD
Fluticasone furoate—Dyspnoea—Irinotecan—lung cancer	0.000231	0.00211	CcSEcCtD
Fluticasone furoate—Nervous system disorder—Cisplatin—lung cancer	0.00023	0.00211	CcSEcCtD
Fluticasone furoate—Cough—Etoposide—lung cancer	0.00023	0.0021	CcSEcCtD
Fluticasone furoate—Headache—Topotecan—lung cancer	0.00023	0.0021	CcSEcCtD
Fluticasone furoate—Rash—Erlotinib—lung cancer	0.000229	0.00209	CcSEcCtD
Fluticasone furoate—Dermatitis—Erlotinib—lung cancer	0.000229	0.00209	CcSEcCtD
Fluticasone furoate—Palpitations—Paclitaxel—lung cancer	0.000229	0.00209	CcSEcCtD
Fluticasone furoate—Immune system disorder—Docetaxel—lung cancer	0.000227	0.00208	CcSEcCtD
Fluticasone furoate—Headache—Erlotinib—lung cancer	0.000227	0.00208	CcSEcCtD
Fluticasone furoate—Mediastinal disorder—Docetaxel—lung cancer	0.000227	0.00207	CcSEcCtD
Fluticasone furoate—Cough—Paclitaxel—lung cancer	0.000226	0.00206	CcSEcCtD
Fluticasone furoate—Dyspnoea—Gemcitabine—lung cancer	0.000225	0.00205	CcSEcCtD
Fluticasone furoate—Nausea—Vinblastine—lung cancer	0.000224	0.00205	CcSEcCtD
Fluticasone furoate—Migraine—Doxorubicin—lung cancer	0.000224	0.00204	CcSEcCtD
Fluticasone furoate—Nausea—Topotecan—lung cancer	0.000218	0.00199	CcSEcCtD
Fluticasone furoate—Nausea—Erlotinib—lung cancer	0.000216	0.00197	CcSEcCtD
Fluticasone furoate—Anaphylactic shock—Etoposide—lung cancer	0.000215	0.00197	CcSEcCtD
Fluticasone furoate—Diarrhoea—Vinorelbine—lung cancer	0.000215	0.00196	CcSEcCtD
Fluticasone furoate—Infection—Etoposide—lung cancer	0.000214	0.00195	CcSEcCtD
Fluticasone furoate—Back pain—Docetaxel—lung cancer	0.000212	0.00194	CcSEcCtD
Fluticasone furoate—Anaphylactic shock—Paclitaxel—lung cancer	0.000211	0.00193	CcSEcCtD
Fluticasone furoate—Infection—Paclitaxel—lung cancer	0.00021	0.00192	CcSEcCtD
Fluticasone furoate—Dyspnoea—Cisplatin—lung cancer	0.00021	0.00191	CcSEcCtD
Fluticasone furoate—Dizziness—Vinorelbine—lung cancer	0.000208	0.0019	CcSEcCtD
Fluticasone furoate—Nervous system disorder—Paclitaxel—lung cancer	0.000207	0.00189	CcSEcCtD
Fluticasone furoate—Body temperature increased—Irinotecan—lung cancer	0.000205	0.00187	CcSEcCtD
Fluticasone furoate—Nasopharyngitis—Doxorubicin—lung cancer	0.000203	0.00186	CcSEcCtD
Fluticasone furoate—Body temperature increased—Gemcitabine—lung cancer	0.000199	0.00182	CcSEcCtD
Fluticasone furoate—Rash—Vinorelbine—lung cancer	0.000198	0.00181	CcSEcCtD
Fluticasone furoate—Dermatitis—Vinorelbine—lung cancer	0.000198	0.00181	CcSEcCtD
Fluticasone furoate—Headache—Vinorelbine—lung cancer	0.000197	0.0018	CcSEcCtD
Fluticasone furoate—Conjunctivitis—Methotrexate—lung cancer	0.000197	0.0018	CcSEcCtD
Fluticasone furoate—Palpitations—Docetaxel—lung cancer	0.000194	0.00177	CcSEcCtD
Fluticasone furoate—Dyspnoea—Etoposide—lung cancer	0.000192	0.00175	CcSEcCtD
Fluticasone furoate—Cough—Docetaxel—lung cancer	0.000191	0.00175	CcSEcCtD
Fluticasone furoate—Epistaxis—Methotrexate—lung cancer	0.000191	0.00174	CcSEcCtD
Fluticasone furoate—Hypersensitivity—Irinotecan—lung cancer	0.000191	0.00174	CcSEcCtD
Fluticasone furoate—Bronchitis—Doxorubicin—lung cancer	0.000189	0.00173	CcSEcCtD
Fluticasone furoate—Dyspnoea—Paclitaxel—lung cancer	0.000188	0.00172	CcSEcCtD
Fluticasone furoate—Nausea—Vinorelbine—lung cancer	0.000186	0.0017	CcSEcCtD
Fluticasone furoate—Body temperature increased—Cisplatin—lung cancer	0.000186	0.0017	CcSEcCtD
Fluticasone furoate—Pharyngitis—Methotrexate—lung cancer	0.00018	0.00165	CcSEcCtD
Fluticasone furoate—Anaphylactic shock—Docetaxel—lung cancer	0.000179	0.00163	CcSEcCtD
Fluticasone furoate—Infection—Docetaxel—lung cancer	0.000178	0.00162	CcSEcCtD
Fluticasone furoate—Diarrhoea—Irinotecan—lung cancer	0.000177	0.00162	CcSEcCtD
Fluticasone furoate—Nervous system disorder—Docetaxel—lung cancer	0.000175	0.0016	CcSEcCtD
Fluticasone furoate—Visual impairment—Methotrexate—lung cancer	0.000175	0.0016	CcSEcCtD
Fluticasone furoate—Hypersensitivity—Cisplatin—lung cancer	0.000173	0.00158	CcSEcCtD
Fluticasone furoate—Diarrhoea—Gemcitabine—lung cancer	0.000173	0.00158	CcSEcCtD
Fluticasone furoate—Dexamethasone—CYP2A6—lung cancer	0.000171	0.0456	CrCbGaD
Fluticasone furoate—Dizziness—Irinotecan—lung cancer	0.000171	0.00156	CcSEcCtD
Fluticasone furoate—Urticaria—Etoposide—lung cancer	0.000171	0.00156	CcSEcCtD
Fluticasone furoate—Body temperature increased—Etoposide—lung cancer	0.00017	0.00156	CcSEcCtD
Fluticasone furoate—Conjunctivitis—Doxorubicin—lung cancer	0.00017	0.00156	CcSEcCtD
Fluticasone furoate—Eye disorder—Methotrexate—lung cancer	0.00017	0.00155	CcSEcCtD
Fluticasone furoate—Urticaria—Paclitaxel—lung cancer	0.000168	0.00153	CcSEcCtD
Fluticasone furoate—Body temperature increased—Paclitaxel—lung cancer	0.000167	0.00152	CcSEcCtD
Fluticasone furoate—Epistaxis—Doxorubicin—lung cancer	0.000165	0.00151	CcSEcCtD
Fluticasone furoate—Immune system disorder—Methotrexate—lung cancer	0.000164	0.0015	CcSEcCtD
Fluticasone furoate—Mediastinal disorder—Methotrexate—lung cancer	0.000164	0.00149	CcSEcCtD
Fluticasone furoate—Rash—Irinotecan—lung cancer	0.000163	0.00149	CcSEcCtD
Fluticasone furoate—Dermatitis—Irinotecan—lung cancer	0.000163	0.00149	CcSEcCtD
Fluticasone furoate—Headache—Irinotecan—lung cancer	0.000162	0.00148	CcSEcCtD
Fluticasone furoate—Diarrhoea—Cisplatin—lung cancer	0.000161	0.00147	CcSEcCtD
Fluticasone furoate—Dyspnoea—Docetaxel—lung cancer	0.00016	0.00146	CcSEcCtD
Fluticasone furoate—Rash—Gemcitabine—lung cancer	0.000159	0.00145	CcSEcCtD
Fluticasone furoate—Dermatitis—Gemcitabine—lung cancer	0.000159	0.00145	CcSEcCtD
Fluticasone furoate—Hypersensitivity—Etoposide—lung cancer	0.000159	0.00145	CcSEcCtD
Fluticasone furoate—Headache—Gemcitabine—lung cancer	0.000158	0.00144	CcSEcCtD
Fluticasone furoate—Triamcinolone—PTGS2—lung cancer	0.000157	0.0419	CrCbGaD
Fluticasone furoate—Pharyngitis—Doxorubicin—lung cancer	0.000156	0.00143	CcSEcCtD
Fluticasone furoate—Hypersensitivity—Paclitaxel—lung cancer	0.000156	0.00142	CcSEcCtD
Fluticasone furoate—Connective tissue disorder—Doxorubicin—lung cancer	0.000154	0.00141	CcSEcCtD
Fluticasone furoate—Nausea—Irinotecan—lung cancer	0.000154	0.0014	CcSEcCtD
Fluticasone furoate—Dexamethasone—ABCG2—lung cancer	0.000153	0.0408	CrCbGaD
Fluticasone furoate—Back pain—Methotrexate—lung cancer	0.000153	0.0014	CcSEcCtD
Fluticasone furoate—Visual impairment—Doxorubicin—lung cancer	0.000151	0.00138	CcSEcCtD
Fluticasone furoate—Nausea—Gemcitabine—lung cancer	0.00015	0.00137	CcSEcCtD
Fluticasone furoate—Rash—Cisplatin—lung cancer	0.000148	0.00135	CcSEcCtD
Fluticasone furoate—Dermatitis—Cisplatin—lung cancer	0.000148	0.00135	CcSEcCtD
Fluticasone furoate—Diarrhoea—Etoposide—lung cancer	0.000147	0.00135	CcSEcCtD
Fluticasone furoate—Eye disorder—Doxorubicin—lung cancer	0.000147	0.00134	CcSEcCtD
Fluticasone furoate—Diarrhoea—Paclitaxel—lung cancer	0.000144	0.00132	CcSEcCtD
Fluticasone furoate—Dizziness—Etoposide—lung cancer	0.000142	0.0013	CcSEcCtD
Fluticasone furoate—Immune system disorder—Doxorubicin—lung cancer	0.000142	0.0013	CcSEcCtD
Fluticasone furoate—Mediastinal disorder—Doxorubicin—lung cancer	0.000142	0.00129	CcSEcCtD
Fluticasone furoate—Body temperature increased—Docetaxel—lung cancer	0.000141	0.00129	CcSEcCtD
Fluticasone furoate—Dizziness—Paclitaxel—lung cancer	0.00014	0.00128	CcSEcCtD
Fluticasone furoate—Nausea—Cisplatin—lung cancer	0.00014	0.00128	CcSEcCtD
Fluticasone furoate—Cough—Methotrexate—lung cancer	0.000138	0.00126	CcSEcCtD
Fluticasone furoate—Rash—Etoposide—lung cancer	0.000136	0.00124	CcSEcCtD
Fluticasone furoate—Dermatitis—Etoposide—lung cancer	0.000136	0.00124	CcSEcCtD
Fluticasone furoate—Headache—Etoposide—lung cancer	0.000135	0.00123	CcSEcCtD
Fluticasone furoate—Rash—Paclitaxel—lung cancer	0.000133	0.00122	CcSEcCtD
Fluticasone furoate—Dermatitis—Paclitaxel—lung cancer	0.000133	0.00122	CcSEcCtD
Fluticasone furoate—Back pain—Doxorubicin—lung cancer	0.000132	0.00121	CcSEcCtD
Fluticasone furoate—Headache—Paclitaxel—lung cancer	0.000132	0.00121	CcSEcCtD
Fluticasone furoate—Hypersensitivity—Docetaxel—lung cancer	0.000132	0.0012	CcSEcCtD
Fluticasone furoate—Anaphylactic shock—Methotrexate—lung cancer	0.000129	0.00118	CcSEcCtD
Fluticasone furoate—Betamethasone—PTGS2—lung cancer	0.000129	0.0343	CrCbGaD
Fluticasone furoate—Infection—Methotrexate—lung cancer	0.000128	0.00117	CcSEcCtD
Fluticasone furoate—Nausea—Etoposide—lung cancer	0.000128	0.00117	CcSEcCtD
Fluticasone furoate—Nervous system disorder—Methotrexate—lung cancer	0.000126	0.00116	CcSEcCtD
Fluticasone furoate—Agitation—Doxorubicin—lung cancer	0.000126	0.00115	CcSEcCtD
Fluticasone furoate—Nausea—Paclitaxel—lung cancer	0.000125	0.00115	CcSEcCtD
Fluticasone furoate—Diarrhoea—Docetaxel—lung cancer	0.000122	0.00112	CcSEcCtD
Fluticasone furoate—Dexamethasone—CYP2E1—lung cancer	0.000122	0.0324	CrCbGaD
Fluticasone furoate—Palpitations—Doxorubicin—lung cancer	0.000121	0.0011	CcSEcCtD
Fluticasone furoate—Dexamethasone—CYP1A1—lung cancer	0.00012	0.0319	CrCbGaD
Fluticasone furoate—Cough—Doxorubicin—lung cancer	0.000119	0.00109	CcSEcCtD
Fluticasone furoate—Dizziness—Docetaxel—lung cancer	0.000118	0.00108	CcSEcCtD
Fluticasone furoate—Dyspnoea—Methotrexate—lung cancer	0.000115	0.00105	CcSEcCtD
Fluticasone furoate—Rash—Docetaxel—lung cancer	0.000113	0.00103	CcSEcCtD
Fluticasone furoate—Dermatitis—Docetaxel—lung cancer	0.000113	0.00103	CcSEcCtD
Fluticasone furoate—Headache—Docetaxel—lung cancer	0.000112	0.00102	CcSEcCtD
Fluticasone furoate—Anaphylactic shock—Doxorubicin—lung cancer	0.000112	0.00102	CcSEcCtD
Fluticasone furoate—Infection—Doxorubicin—lung cancer	0.000111	0.00101	CcSEcCtD
Fluticasone furoate—Betamethasone—ABCB1—lung cancer	0.00011	0.0292	CrCbGaD
Fluticasone furoate—Nervous system disorder—Doxorubicin—lung cancer	0.00011	0.001	CcSEcCtD
Fluticasone furoate—Nausea—Docetaxel—lung cancer	0.000106	0.000971	CcSEcCtD
Fluticasone furoate—Urticaria—Methotrexate—lung cancer	0.000102	0.000936	CcSEcCtD
Fluticasone furoate—Body temperature increased—Methotrexate—lung cancer	0.000102	0.000932	CcSEcCtD
Fluticasone furoate—Dyspnoea—Doxorubicin—lung cancer	9.95e-05	0.00091	CcSEcCtD
Fluticasone furoate—NR3C1—Glucocorticoid receptor regulatory network—IL2—lung cancer	9.77e-05	0.00183	CbGpPWpGaD
Fluticasone furoate—ABCB1—Allograft Rejection—FASLG—lung cancer	9.62e-05	0.0018	CbGpPWpGaD
Fluticasone furoate—NR3C1—Regulation of nuclear SMAD2/3 signaling—JUN—lung cancer	9.6e-05	0.0018	CbGpPWpGaD
Fluticasone furoate—NR3C1—Glucocorticoid receptor regulatory network—JUN—lung cancer	9.5e-05	0.00178	CbGpPWpGaD
Fluticasone furoate—Hypersensitivity—Methotrexate—lung cancer	9.5e-05	0.000868	CcSEcCtD
Fluticasone furoate—ABCB1—Integrated Pancreatic Cancer Pathway—RARB—lung cancer	9.46e-05	0.00177	CbGpPWpGaD
Fluticasone furoate—NR3C1—Gene Expression—EIF2B4—lung cancer	9.43e-05	0.00177	CbGpPWpGaD
Fluticasone furoate—NR3C1—SIDS Susceptibility Pathways—HIF1A—lung cancer	9.42e-05	0.00176	CbGpPWpGaD
Fluticasone furoate—CYP3A4—Tryptophan metabolism—CYP1A1—lung cancer	9.32e-05	0.00175	CbGpPWpGaD
Fluticasone furoate—NR3C1—Regulation of nuclear SMAD2/3 signaling—CDKN1A—lung cancer	9.3e-05	0.00174	CbGpPWpGaD
Fluticasone furoate—NR3C1—Glucocorticoid receptor regulatory network—CDKN1A—lung cancer	9.21e-05	0.00173	CbGpPWpGaD
Fluticasone furoate—CYP3A4—Biological oxidations—CYP2A7—lung cancer	9.14e-05	0.00171	CbGpPWpGaD
Fluticasone furoate—ABCB1—Transmembrane transport of small molecules—SLC34A2—lung cancer	9.04e-05	0.00169	CbGpPWpGaD
Fluticasone furoate—CYP3A4—Metapathway biotransformation—CYP2A7—lung cancer	9.02e-05	0.00169	CbGpPWpGaD
Fluticasone furoate—Urticaria—Doxorubicin—lung cancer	8.87e-05	0.000811	CcSEcCtD
Fluticasone furoate—NR3C1—Adipogenesis—RB1—lung cancer	8.87e-05	0.00166	CbGpPWpGaD
Fluticasone furoate—NR3C1—Regulation of nuclear SMAD2/3 signaling—EP300—lung cancer	8.85e-05	0.00166	CbGpPWpGaD
Fluticasone furoate—Body temperature increased—Doxorubicin—lung cancer	8.83e-05	0.000807	CcSEcCtD
Fluticasone furoate—Diarrhoea—Methotrexate—lung cancer	8.82e-05	0.000806	CcSEcCtD
Fluticasone furoate—NR3C1—Glucocorticoid receptor regulatory network—EP300—lung cancer	8.77e-05	0.00164	CbGpPWpGaD
Fluticasone furoate—NR3C1—Generic Transcription Pathway—RARB—lung cancer	8.74e-05	0.00164	CbGpPWpGaD
Fluticasone furoate—NR3C1—FOXA2 and FOXA3 transcription factor networks—AKT1—lung cancer	8.72e-05	0.00163	CbGpPWpGaD
Fluticasone furoate—NR3C1—AP-1 transcription factor network—MYC—lung cancer	8.67e-05	0.00162	CbGpPWpGaD
Fluticasone furoate—Dizziness—Methotrexate—lung cancer	8.53e-05	0.000779	CcSEcCtD
Fluticasone furoate—NR3C1—Generic Transcription Pathway—NPPA—lung cancer	8.52e-05	0.0016	CbGpPWpGaD
Fluticasone furoate—CYP3A4—Phase 1 - Functionalization of compounds—CYP2E1—lung cancer	8.5e-05	0.00159	CbGpPWpGaD
Fluticasone furoate—NR3C1—Gene Expression—HNRNPA2B1—lung cancer	8.4e-05	0.00157	CbGpPWpGaD
Fluticasone furoate—ABCB1—Integrated Pancreatic Cancer Pathway—HPGDS—lung cancer	8.27e-05	0.00155	CbGpPWpGaD
Fluticasone furoate—ABCB1—HIF-1-alpha transcription factor network—CREBBP—lung cancer	8.23e-05	0.00154	CbGpPWpGaD
Fluticasone furoate—Hypersensitivity—Doxorubicin—lung cancer	8.23e-05	0.000752	CcSEcCtD
Fluticasone furoate—CYP3A4—Biological oxidations—GSTA3—lung cancer	8.15e-05	0.00153	CbGpPWpGaD
Fluticasone furoate—Rash—Methotrexate—lung cancer	8.13e-05	0.000743	CcSEcCtD
Fluticasone furoate—Dermatitis—Methotrexate—lung cancer	8.12e-05	0.000742	CcSEcCtD
Fluticasone furoate—Headache—Methotrexate—lung cancer	8.08e-05	0.000738	CcSEcCtD
Fluticasone furoate—CYP3A4—Metapathway biotransformation—GSTA3—lung cancer	8.04e-05	0.00151	CbGpPWpGaD
Fluticasone furoate—NR3C1—Glucocorticoid receptor regulatory network—MAPK3—lung cancer	7.85e-05	0.00147	CbGpPWpGaD
Fluticasone furoate—NR3C1—Regulation of nuclear SMAD2/3 signaling—MYC—lung cancer	7.71e-05	0.00145	CbGpPWpGaD
Fluticasone furoate—NR3C1—SIDS Susceptibility Pathways—IL6R—lung cancer	7.71e-05	0.00144	CbGpPWpGaD
Fluticasone furoate—NR3C1—SIDS Susceptibility Pathways—CREBBP—lung cancer	7.7e-05	0.00144	CbGpPWpGaD
Fluticasone furoate—NR3C1—Gene Expression—KHSRP—lung cancer	7.68e-05	0.00144	CbGpPWpGaD
Fluticasone furoate—Nausea—Methotrexate—lung cancer	7.66e-05	0.0007	CcSEcCtD
Fluticasone furoate—Diarrhoea—Doxorubicin—lung cancer	7.64e-05	0.000698	CcSEcCtD
Fluticasone furoate—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A1—lung cancer	7.53e-05	0.00141	CbGpPWpGaD
Fluticasone furoate—Dexamethasone—PTGS2—lung cancer	7.5e-05	0.02	CrCbGaD
Fluticasone furoate—CYP3A4—Biological oxidations—GSTA4—lung cancer	7.45e-05	0.0014	CbGpPWpGaD
Fluticasone furoate—CYP3A4—Oxidation by Cytochrome P450—CYP1A1—lung cancer	7.43e-05	0.00139	CbGpPWpGaD
Fluticasone furoate—Dizziness—Doxorubicin—lung cancer	7.38e-05	0.000675	CcSEcCtD
Fluticasone furoate—ABCB1—Integrated Pancreatic Cancer Pathway—ANXA1—lung cancer	7.37e-05	0.00138	CbGpPWpGaD
Fluticasone furoate—CYP3A4—Metapathway biotransformation—GSTA4—lung cancer	7.35e-05	0.00138	CbGpPWpGaD
Fluticasone furoate—CYP3A4—Biological oxidations—GSTA2—lung cancer	7.26e-05	0.00136	CbGpPWpGaD
Fluticasone furoate—ABCB1—Allograft Rejection—CASP8—lung cancer	7.16e-05	0.00134	CbGpPWpGaD
Fluticasone furoate—NR3C1—AP-1 transcription factor network—TP53—lung cancer	7.12e-05	0.00133	CbGpPWpGaD
Fluticasone furoate—Rash—Doxorubicin—lung cancer	7.04e-05	0.000643	CcSEcCtD
Fluticasone furoate—Dermatitis—Doxorubicin—lung cancer	7.03e-05	0.000643	CcSEcCtD
Fluticasone furoate—CYP3A4—Biological oxidations—GSTA1—lung cancer	7.01e-05	0.00131	CbGpPWpGaD
Fluticasone furoate—Headache—Doxorubicin—lung cancer	7e-05	0.000639	CcSEcCtD
Fluticasone furoate—ABCB1—Integrated Pancreatic Cancer Pathway—APP—lung cancer	6.98e-05	0.00131	CbGpPWpGaD
Fluticasone furoate—ABCB1—Transmembrane transport of small molecules—SLC22A18—lung cancer	6.85e-05	0.00128	CbGpPWpGaD
Fluticasone furoate—NR3C1—Gene Expression—EIF2B5—lung cancer	6.72e-05	0.00126	CbGpPWpGaD
Fluticasone furoate—Nausea—Doxorubicin—lung cancer	6.63e-05	0.000606	CcSEcCtD
Fluticasone furoate—CYP3A4—Metapathway biotransformation—AKR1C1—lung cancer	6.62e-05	0.00124	CbGpPWpGaD
Fluticasone furoate—ABCB1—Integrated Pancreatic Cancer Pathway—JUNB—lung cancer	6.61e-05	0.00124	CbGpPWpGaD
Fluticasone furoate—NR3C1—AP-1 transcription factor network—IL6—lung cancer	6.52e-05	0.00122	CbGpPWpGaD
Fluticasone furoate—CYP3A4—Biological oxidations—UGT1A1—lung cancer	6.51e-05	0.00122	CbGpPWpGaD
Fluticasone furoate—NR3C1—Generic Transcription Pathway—NOTCH3—lung cancer	6.46e-05	0.00121	CbGpPWpGaD
Fluticasone furoate—CYP3A4—Metapathway biotransformation—UGT1A1—lung cancer	6.42e-05	0.0012	CbGpPWpGaD
Fluticasone furoate—Dexamethasone—ABCB1—lung cancer	6.38e-05	0.017	CrCbGaD
Fluticasone furoate—NR3C1—Adipogenesis—CDKN1A—lung cancer	6.37e-05	0.00119	CbGpPWpGaD
Fluticasone furoate—NR3C1—Glucocorticoid receptor regulatory network—TP53—lung cancer	6.27e-05	0.00118	CbGpPWpGaD
Fluticasone furoate—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—lung cancer	6.2e-05	0.00116	CbGpPWpGaD
Fluticasone furoate—NR3C1—Generic Transcription Pathway—JUNB—lung cancer	6.12e-05	0.00115	CbGpPWpGaD
Fluticasone furoate—NR3C1—SIDS Susceptibility Pathways—CXCL8—lung cancer	6.11e-05	0.00114	CbGpPWpGaD
Fluticasone furoate—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A1—lung cancer	6.11e-05	0.00114	CbGpPWpGaD
Fluticasone furoate—ABCB1—HIF-1-alpha transcription factor network—JUN—lung cancer	6.07e-05	0.00114	CbGpPWpGaD
Fluticasone furoate—NR3C1—Gene Expression—DICER1—lung cancer	6.07e-05	0.00114	CbGpPWpGaD
Fluticasone furoate—ABCB1—Integrated Pancreatic Cancer Pathway—STK11—lung cancer	6.01e-05	0.00113	CbGpPWpGaD
Fluticasone furoate—NR3C1—SIDS Susceptibility Pathways—CASP3—lung cancer	5.85e-05	0.0011	CbGpPWpGaD
Fluticasone furoate—CYP3A4—Tryptophan metabolism—MDM2—lung cancer	5.75e-05	0.00108	CbGpPWpGaD
Fluticasone furoate—NR3C1—Glucocorticoid receptor regulatory network—IL6—lung cancer	5.74e-05	0.00108	CbGpPWpGaD
Fluticasone furoate—NR3C1—Adipogenesis—STAT3—lung cancer	5.69e-05	0.00107	CbGpPWpGaD
Fluticasone furoate—NR3C1—SIDS Susceptibility Pathways—JUN—lung cancer	5.68e-05	0.00106	CbGpPWpGaD
Fluticasone furoate—ABCB1—Allograft Rejection—CXCL8—lung cancer	5.66e-05	0.00106	CbGpPWpGaD
Fluticasone furoate—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—lung cancer	5.62e-05	0.00105	CbGpPWpGaD
Fluticasone furoate—ABCB1—HIF-1-alpha transcription factor network—EP300—lung cancer	5.6e-05	0.00105	CbGpPWpGaD
Fluticasone furoate—CYP3A4—Biological oxidations—HPGDS—lung cancer	5.54e-05	0.00104	CbGpPWpGaD
Fluticasone furoate—ABCB1—Allograft Rejection—CASP3—lung cancer	5.42e-05	0.00101	CbGpPWpGaD
Fluticasone furoate—ABCB1—Allograft Rejection—IL2—lung cancer	5.41e-05	0.00101	CbGpPWpGaD
Fluticasone furoate—CYP3A4—Biological oxidations—GSTT1—lung cancer	5.37e-05	0.00101	CbGpPWpGaD
Fluticasone furoate—NR3C1—Regulation of nuclear SMAD2/3 signaling—AKT1—lung cancer	5.35e-05	0.001	CbGpPWpGaD
Fluticasone furoate—CYP3A4—Biological oxidations—CYP2A6—lung cancer	5.31e-05	0.000995	CbGpPWpGaD
Fluticasone furoate—CYP3A4—Biological oxidations—GCLC—lung cancer	5.31e-05	0.000995	CbGpPWpGaD
Fluticasone furoate—ABCB1—HIF-1-alpha transcription factor network—VEGFA—lung cancer	5.31e-05	0.000994	CbGpPWpGaD
Fluticasone furoate—NR3C1—Glucocorticoid receptor regulatory network—AKT1—lung cancer	5.3e-05	0.000992	CbGpPWpGaD
Fluticasone furoate—NR3C1—Gene Expression—SKI—lung cancer	5.24e-05	0.000982	CbGpPWpGaD
Fluticasone furoate—NR3C1—SIDS Susceptibility Pathways—EP300—lung cancer	5.24e-05	0.000982	CbGpPWpGaD
Fluticasone furoate—ABCB1—Integrated Pancreatic Cancer Pathway—TYMS—lung cancer	5.17e-05	0.000968	CbGpPWpGaD
Fluticasone furoate—NR3C1—SIDS Susceptibility Pathways—VEGFA—lung cancer	4.96e-05	0.00093	CbGpPWpGaD
Fluticasone furoate—ABCB1—Integrated Pancreatic Cancer Pathway—FASLG—lung cancer	4.75e-05	0.000889	CbGpPWpGaD
Fluticasone furoate—ABCB1—Metabolism—COL4A3BP—lung cancer	4.63e-05	0.000868	CbGpPWpGaD
Fluticasone furoate—ABCB1—Metabolism—AZIN2—lung cancer	4.63e-05	0.000868	CbGpPWpGaD
Fluticasone furoate—ABCB1—Allograft Rejection—VEGFA—lung cancer	4.6e-05	0.000861	CbGpPWpGaD
Fluticasone furoate—CYP3A4—Phase 1 - Functionalization of compounds—POMC—lung cancer	4.55e-05	0.000853	CbGpPWpGaD
Fluticasone furoate—CYP3A4—Biological oxidations—CYP2E1—lung cancer	4.51e-05	0.000846	CbGpPWpGaD
Fluticasone furoate—CYP3A4—Metapathway biotransformation—CYP2E1—lung cancer	4.45e-05	0.000834	CbGpPWpGaD
Fluticasone furoate—ABCB1—Integrated Pancreatic Cancer Pathway—FGFR1—lung cancer	4.37e-05	0.000819	CbGpPWpGaD
Fluticasone furoate—NR3C1—Gene Expression—RARB—lung cancer	4.21e-05	0.000789	CbGpPWpGaD
Fluticasone furoate—ABCB1—Transmembrane transport of small molecules—ABCC3—lung cancer	4.11e-05	0.000769	CbGpPWpGaD
Fluticasone furoate—NR3C1—Gene Expression—NPPA—lung cancer	4.1e-05	0.000769	CbGpPWpGaD
Fluticasone furoate—NR3C1—Adipogenesis—IL6—lung cancer	3.97e-05	0.000744	CbGpPWpGaD
Fluticasone furoate—ABCB1—Metabolism—ATP5H—lung cancer	3.94e-05	0.000738	CbGpPWpGaD
Fluticasone furoate—ABCB1—Integrated Pancreatic Cancer Pathway—APC—lung cancer	3.79e-05	0.00071	CbGpPWpGaD
Fluticasone furoate—ABCB1—Integrated Pancreatic Cancer Pathway—EGF—lung cancer	3.75e-05	0.000702	CbGpPWpGaD
Fluticasone furoate—CYP3A4—Biological oxidations—GSTP1—lung cancer	3.72e-05	0.000698	CbGpPWpGaD
Fluticasone furoate—ABCB1—Transmembrane transport of small molecules—GNG11—lung cancer	3.72e-05	0.000697	CbGpPWpGaD
Fluticasone furoate—CYP3A4—Metapathway biotransformation—GSTP1—lung cancer	3.67e-05	0.000688	CbGpPWpGaD
Fluticasone furoate—ABCB1—Integrated Pancreatic Cancer Pathway—CASP8—lung cancer	3.53e-05	0.000662	CbGpPWpGaD
Fluticasone furoate—NR3C1—Gene Expression—HSPB1—lung cancer	3.53e-05	0.000661	CbGpPWpGaD
Fluticasone furoate—ABCB1—Integrated Pancreatic Cancer Pathway—CREBBP—lung cancer	3.52e-05	0.000659	CbGpPWpGaD
Fluticasone furoate—ABCB1—Metabolism—PLBD1—lung cancer	3.51e-05	0.000657	CbGpPWpGaD
Fluticasone furoate—NR3C1—SIDS Susceptibility Pathways—IL6—lung cancer	3.43e-05	0.000643	CbGpPWpGaD
Fluticasone furoate—CYP3A4—Biological oxidations—GSTM1—lung cancer	3.42e-05	0.000641	CbGpPWpGaD
Fluticasone furoate—ABCB1—HIF-1-alpha transcription factor network—AKT1—lung cancer	3.39e-05	0.000634	CbGpPWpGaD
Fluticasone furoate—CYP3A4—Metapathway biotransformation—GSTM1—lung cancer	3.37e-05	0.000632	CbGpPWpGaD
Fluticasone furoate—ABCB1—Integrated Pancreatic Cancer Pathway—MAP2K1—lung cancer	3.36e-05	0.000629	CbGpPWpGaD
Fluticasone furoate—ABCB1—Transmembrane transport of small molecules—ABCG2—lung cancer	3.35e-05	0.000627	CbGpPWpGaD
Fluticasone furoate—ABCB1—Transmembrane transport of small molecules—ADCY1—lung cancer	3.35e-05	0.000627	CbGpPWpGaD
Fluticasone furoate—NR3C1—Generic Transcription Pathway—CREBBP—lung cancer	3.25e-05	0.000609	CbGpPWpGaD
Fluticasone furoate—CYP3A4—Biological oxidations—CYP1A1—lung cancer	3.24e-05	0.000608	CbGpPWpGaD
Fluticasone furoate—ABCB1—Metabolism—HSD17B10—lung cancer	3.21e-05	0.000601	CbGpPWpGaD
Fluticasone furoate—CYP3A4—Metapathway biotransformation—CYP1A1—lung cancer	3.2e-05	0.000599	CbGpPWpGaD
Fluticasone furoate—ABCB1—Transmembrane transport of small molecules—TF—lung cancer	3.11e-05	0.000583	CbGpPWpGaD
Fluticasone furoate—NR3C1—Gene Expression—NOTCH3—lung cancer	3.11e-05	0.000583	CbGpPWpGaD
Fluticasone furoate—ABCB1—Integrated Pancreatic Cancer Pathway—MDM2—lung cancer	2.99e-05	0.000559	CbGpPWpGaD
Fluticasone furoate—ABCB1—Metabolism—CKB—lung cancer	2.98e-05	0.000559	CbGpPWpGaD
Fluticasone furoate—ABCB1—Integrated Pancreatic Cancer Pathway—RAF1—lung cancer	2.98e-05	0.000558	CbGpPWpGaD
Fluticasone furoate—NR3C1—Gene Expression—JUNB—lung cancer	2.94e-05	0.000552	CbGpPWpGaD
Fluticasone furoate—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—lung cancer	2.94e-05	0.000552	CbGpPWpGaD
Fluticasone furoate—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—lung cancer	2.88e-05	0.000539	CbGpPWpGaD
Fluticasone furoate—CYP3A4—Metabolism—COL4A3BP—lung cancer	2.85e-05	0.000534	CbGpPWpGaD
Fluticasone furoate—CYP3A4—Metabolism—AZIN2—lung cancer	2.85e-05	0.000534	CbGpPWpGaD
Fluticasone furoate—ABCB1—Metabolism—GSTM2—lung cancer	2.81e-05	0.000526	CbGpPWpGaD
Fluticasone furoate—ABCB1—Metabolism—CNDP2—lung cancer	2.81e-05	0.000526	CbGpPWpGaD
Fluticasone furoate—ABCB1—Metabolism—MTMR3—lung cancer	2.73e-05	0.000511	CbGpPWpGaD
Fluticasone furoate—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—lung cancer	2.67e-05	0.000501	CbGpPWpGaD
Fluticasone furoate—ABCB1—Metabolism—PGAM1—lung cancer	2.66e-05	0.000498	CbGpPWpGaD
Fluticasone furoate—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—lung cancer	2.6e-05	0.000487	CbGpPWpGaD
Fluticasone furoate—ABCB1—Integrated Pancreatic Cancer Pathway—JUN—lung cancer	2.6e-05	0.000486	CbGpPWpGaD
Fluticasone furoate—ABCB1—Metabolism—CYP2A7—lung cancer	2.54e-05	0.000475	CbGpPWpGaD
Fluticasone furoate—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1A—lung cancer	2.52e-05	0.000471	CbGpPWpGaD
Fluticasone furoate—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—lung cancer	2.51e-05	0.00047	CbGpPWpGaD
Fluticasone furoate—ABCB1—Metabolism—SDC4—lung cancer	2.48e-05	0.000465	CbGpPWpGaD
Fluticasone furoate—CYP3A4—Metabolism—ATP5H—lung cancer	2.43e-05	0.000454	CbGpPWpGaD
Fluticasone furoate—CYP3A4—Biological oxidations—POMC—lung cancer	2.42e-05	0.000453	CbGpPWpGaD
Fluticasone furoate—ABCB1—Integrated Pancreatic Cancer Pathway—EP300—lung cancer	2.39e-05	0.000449	CbGpPWpGaD
Fluticasone furoate—ABCB1—Integrated Pancreatic Cancer Pathway—SRC—lung cancer	2.33e-05	0.000436	CbGpPWpGaD
Fluticasone furoate—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—lung cancer	2.27e-05	0.000425	CbGpPWpGaD
Fluticasone furoate—ABCB1—Metabolism—GSTA3—lung cancer	2.26e-05	0.000424	CbGpPWpGaD
Fluticasone furoate—ABCB1—Metabolism—RRM1—lung cancer	2.26e-05	0.000424	CbGpPWpGaD
Fluticasone furoate—CYP3A4—Metabolism—PLBD1—lung cancer	2.16e-05	0.000405	CbGpPWpGaD
Fluticasone furoate—ABCB1—Transmembrane transport of small molecules—AVP—lung cancer	2.16e-05	0.000404	CbGpPWpGaD
Fluticasone furoate—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK3—lung cancer	2.15e-05	0.000402	CbGpPWpGaD
Fluticasone furoate—NR3C1—Gene Expression—ERCC2—lung cancer	2.14e-05	0.0004	CbGpPWpGaD
Fluticasone furoate—ABCB1—Metabolism—B4GALT5—lung cancer	2.13e-05	0.000398	CbGpPWpGaD
Fluticasone furoate—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—lung cancer	2.09e-05	0.000391	CbGpPWpGaD
Fluticasone furoate—ABCB1—Metabolism—GSTA4—lung cancer	2.07e-05	0.000387	CbGpPWpGaD
Fluticasone furoate—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—lung cancer	2.04e-05	0.000382	CbGpPWpGaD
Fluticasone furoate—ABCB1—Metabolism—GSTA2—lung cancer	2.02e-05	0.000378	CbGpPWpGaD
Fluticasone furoate—CYP3A4—Metabolism—HSD17B10—lung cancer	1.98e-05	0.00037	CbGpPWpGaD
Fluticasone furoate—ABCB1—Metabolism—GSTA1—lung cancer	1.94e-05	0.000364	CbGpPWpGaD
Fluticasone furoate—NR3C1—Generic Transcription Pathway—MYC—lung cancer	1.93e-05	0.000361	CbGpPWpGaD
Fluticasone furoate—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—lung cancer	1.93e-05	0.000361	CbGpPWpGaD
Fluticasone furoate—ABCB1—Metabolism—ABCC3—lung cancer	1.92e-05	0.00036	CbGpPWpGaD
Fluticasone furoate—ABCB1—Metabolism—AKR1C1—lung cancer	1.86e-05	0.000349	CbGpPWpGaD
Fluticasone furoate—CYP3A4—Metabolism—CKB—lung cancer	1.84e-05	0.000344	CbGpPWpGaD
Fluticasone furoate—ABCB1—Metabolism—UGT1A1—lung cancer	1.81e-05	0.000339	CbGpPWpGaD
Fluticasone furoate—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—lung cancer	1.77e-05	0.000332	CbGpPWpGaD
Fluticasone furoate—ABCB1—Metabolism—GNG11—lung cancer	1.74e-05	0.000327	CbGpPWpGaD
Fluticasone furoate—CYP3A4—Metabolism—CNDP2—lung cancer	1.73e-05	0.000324	CbGpPWpGaD
Fluticasone furoate—CYP3A4—Metabolism—GSTM2—lung cancer	1.73e-05	0.000324	CbGpPWpGaD
Fluticasone furoate—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—lung cancer	1.71e-05	0.000321	CbGpPWpGaD
Fluticasone furoate—CYP3A4—Metabolism—MTMR3—lung cancer	1.68e-05	0.000315	CbGpPWpGaD
Fluticasone furoate—ABCB1—Metabolism—ALDOA—lung cancer	1.66e-05	0.000311	CbGpPWpGaD
Fluticasone furoate—ABCB1—Transmembrane transport of small molecules—APOA1—lung cancer	1.65e-05	0.000309	CbGpPWpGaD
Fluticasone furoate—CYP3A4—Metabolism—PGAM1—lung cancer	1.64e-05	0.000307	CbGpPWpGaD
Fluticasone furoate—ABCB1—Metabolism—NCOA3—lung cancer	1.61e-05	0.000302	CbGpPWpGaD
Fluticasone furoate—ABCB1—Metabolism—ADCY1—lung cancer	1.57e-05	0.000294	CbGpPWpGaD
Fluticasone furoate—ABCB1—Metabolism—ABCG2—lung cancer	1.57e-05	0.000294	CbGpPWpGaD
Fluticasone furoate—NR3C1—Gene Expression—CREBBP—lung cancer	1.57e-05	0.000293	CbGpPWpGaD
Fluticasone furoate—CYP3A4—Metabolism—CYP2A7—lung cancer	1.56e-05	0.000293	CbGpPWpGaD
Fluticasone furoate—ABCB1—Metabolism—HPGDS—lung cancer	1.54e-05	0.000288	CbGpPWpGaD
Fluticasone furoate—ABCB1—Metabolism—ENO2—lung cancer	1.54e-05	0.000288	CbGpPWpGaD
Fluticasone furoate—CYP3A4—Metabolism—SDC4—lung cancer	1.53e-05	0.000287	CbGpPWpGaD
Fluticasone furoate—ABCB1—Metabolism—PPP2R1B—lung cancer	1.53e-05	0.000286	CbGpPWpGaD
Fluticasone furoate—ABCB1—Metabolism—GSTT1—lung cancer	1.49e-05	0.000279	CbGpPWpGaD
Fluticasone furoate—ABCB1—Metabolism—GCLC—lung cancer	1.47e-05	0.000276	CbGpPWpGaD
Fluticasone furoate—ABCB1—Metabolism—CYP2A6—lung cancer	1.47e-05	0.000276	CbGpPWpGaD
Fluticasone furoate—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—lung cancer	1.45e-05	0.000271	CbGpPWpGaD
Fluticasone furoate—ABCB1—Metabolism—ENO1—lung cancer	1.4e-05	0.000262	CbGpPWpGaD
Fluticasone furoate—ABCB1—Transmembrane transport of small molecules—CREBBP—lung cancer	1.4e-05	0.000262	CbGpPWpGaD
Fluticasone furoate—CYP3A4—Metabolism—GSTA3—lung cancer	1.39e-05	0.000261	CbGpPWpGaD
Fluticasone furoate—CYP3A4—Metabolism—RRM1—lung cancer	1.39e-05	0.000261	CbGpPWpGaD
Fluticasone furoate—CYP3A4—Metabolism—B4GALT5—lung cancer	1.31e-05	0.000245	CbGpPWpGaD
Fluticasone furoate—ABCB1—Transmembrane transport of small molecules—ALB—lung cancer	1.31e-05	0.000245	CbGpPWpGaD
Fluticasone furoate—CYP3A4—Metabolism—GSTA4—lung cancer	1.27e-05	0.000239	CbGpPWpGaD
Fluticasone furoate—ABCB1—Metabolism—CYP2E1—lung cancer	1.25e-05	0.000235	CbGpPWpGaD
Fluticasone furoate—CYP3A4—Metabolism—GSTA2—lung cancer	1.24e-05	0.000233	CbGpPWpGaD
Fluticasone furoate—ABCB1—Metabolism—NQO1—lung cancer	1.24e-05	0.000232	CbGpPWpGaD
Fluticasone furoate—CYP3A4—Metabolism—GSTA1—lung cancer	1.2e-05	0.000224	CbGpPWpGaD
Fluticasone furoate—CYP3A4—Metabolism—ABCC3—lung cancer	1.18e-05	0.000222	CbGpPWpGaD
Fluticasone furoate—ABCB1—Transmembrane transport of small molecules—RAF1—lung cancer	1.18e-05	0.000221	CbGpPWpGaD
Fluticasone furoate—CYP3A4—Metabolism—AKR1C1—lung cancer	1.15e-05	0.000215	CbGpPWpGaD
Fluticasone furoate—ABCB1—Metabolism—STK11—lung cancer	1.12e-05	0.000209	CbGpPWpGaD
Fluticasone furoate—CYP3A4—Metabolism—UGT1A1—lung cancer	1.11e-05	0.000209	CbGpPWpGaD
Fluticasone furoate—CYP3A4—Metabolism—GNG11—lung cancer	1.07e-05	0.000201	CbGpPWpGaD
Fluticasone furoate—ABCB1—Metabolism—GSTP1—lung cancer	1.03e-05	0.000194	CbGpPWpGaD
Fluticasone furoate—CYP3A4—Metabolism—ALDOA—lung cancer	1.02e-05	0.000192	CbGpPWpGaD
Fluticasone furoate—ABCB1—Metabolism—CAT—lung cancer	1.01e-05	0.000188	CbGpPWpGaD
Fluticasone furoate—CYP3A4—Metabolism—NCOA3—lung cancer	9.93e-06	0.000186	CbGpPWpGaD
Fluticasone furoate—CYP3A4—Metabolism—ADCY1—lung cancer	9.66e-06	0.000181	CbGpPWpGaD
Fluticasone furoate—CYP3A4—Metabolism—ABCG2—lung cancer	9.66e-06	0.000181	CbGpPWpGaD
Fluticasone furoate—ABCB1—Metabolism—TYMS—lung cancer	9.61e-06	0.00018	CbGpPWpGaD
Fluticasone furoate—NR3C1—Gene Expression—MAPK3—lung cancer	9.55e-06	0.000179	CbGpPWpGaD
Fluticasone furoate—ABCB1—Metabolism—GSTM1—lung cancer	9.5e-06	0.000178	CbGpPWpGaD
Fluticasone furoate—CYP3A4—Metabolism—ENO2—lung cancer	9.47e-06	0.000177	CbGpPWpGaD
Fluticasone furoate—CYP3A4—Metabolism—HPGDS—lung cancer	9.47e-06	0.000177	CbGpPWpGaD
Fluticasone furoate—CYP3A4—Metabolism—PPP2R1B—lung cancer	9.41e-06	0.000176	CbGpPWpGaD
Fluticasone furoate—NR3C1—Gene Expression—MYC—lung cancer	9.29e-06	0.000174	CbGpPWpGaD
Fluticasone furoate—CYP3A4—Metabolism—GSTT1—lung cancer	9.19e-06	0.000172	CbGpPWpGaD
Fluticasone furoate—CYP3A4—Metabolism—GCLC—lung cancer	9.08e-06	0.00017	CbGpPWpGaD
Fluticasone furoate—CYP3A4—Metabolism—CYP2A6—lung cancer	9.08e-06	0.00017	CbGpPWpGaD
Fluticasone furoate—ABCB1—Metabolism—CYP1A1—lung cancer	9e-06	0.000169	CbGpPWpGaD
Fluticasone furoate—ABCB1—Metabolism—ERCC2—lung cancer	8.93e-06	0.000167	CbGpPWpGaD
Fluticasone furoate—CYP3A4—Metabolism—ENO1—lung cancer	8.61e-06	0.000161	CbGpPWpGaD
Fluticasone furoate—ABCB1—Metabolism—APOA1—lung cancer	7.72e-06	0.000145	CbGpPWpGaD
Fluticasone furoate—CYP3A4—Metabolism—CYP2E1—lung cancer	7.72e-06	0.000145	CbGpPWpGaD
Fluticasone furoate—CYP3A4—Metabolism—NQO1—lung cancer	7.63e-06	0.000143	CbGpPWpGaD
Fluticasone furoate—ABCB1—Metabolism—PIK3CG—lung cancer	7.05e-06	0.000132	CbGpPWpGaD
Fluticasone furoate—CYP3A4—Metabolism—STK11—lung cancer	6.88e-06	0.000129	CbGpPWpGaD
Fluticasone furoate—ABCB1—Metabolism—POMC—lung cancer	6.71e-06	0.000126	CbGpPWpGaD
Fluticasone furoate—ABCB1—Metabolism—CREBBP—lung cancer	6.54e-06	0.000122	CbGpPWpGaD
Fluticasone furoate—NR3C1—Gene Expression—AKT1—lung cancer	6.44e-06	0.000121	CbGpPWpGaD
Fluticasone furoate—CYP3A4—Metabolism—GSTP1—lung cancer	6.37e-06	0.000119	CbGpPWpGaD
Fluticasone furoate—ABCB1—Metabolism—PIK3CD—lung cancer	6.2e-06	0.000116	CbGpPWpGaD
Fluticasone furoate—CYP3A4—Metabolism—CAT—lung cancer	6.2e-06	0.000116	CbGpPWpGaD
Fluticasone furoate—ABCB1—Metabolism—ALB—lung cancer	6.12e-06	0.000115	CbGpPWpGaD
Fluticasone furoate—CYP3A4—Metabolism—ABCB1—lung cancer	6.03e-06	0.000113	CbGpPWpGaD
Fluticasone furoate—CYP3A4—Metabolism—TYMS—lung cancer	5.92e-06	0.000111	CbGpPWpGaD
Fluticasone furoate—CYP3A4—Metabolism—GSTM1—lung cancer	5.85e-06	0.00011	CbGpPWpGaD
Fluticasone furoate—CYP3A4—Metabolism—CYP1A1—lung cancer	5.55e-06	0.000104	CbGpPWpGaD
Fluticasone furoate—CYP3A4—Metabolism—ERCC2—lung cancer	5.5e-06	0.000103	CbGpPWpGaD
Fluticasone furoate—ABCB1—Metabolism—PIK3CB—lung cancer	5.4e-06	0.000101	CbGpPWpGaD
Fluticasone furoate—ABCB1—Metabolism—PTGS2—lung cancer	5.35e-06	0.0001	CbGpPWpGaD
Fluticasone furoate—CYP3A4—Metabolism—APOA1—lung cancer	4.76e-06	8.92e-05	CbGpPWpGaD
Fluticasone furoate—ABCB1—Metabolism—PTEN—lung cancer	4.67e-06	8.75e-05	CbGpPWpGaD
Fluticasone furoate—ABCB1—Metabolism—EP300—lung cancer	4.45e-06	8.34e-05	CbGpPWpGaD
Fluticasone furoate—CYP3A4—Metabolism—PIK3CG—lung cancer	4.34e-06	8.14e-05	CbGpPWpGaD
Fluticasone furoate—CYP3A4—Metabolism—POMC—lung cancer	4.14e-06	7.75e-05	CbGpPWpGaD
Fluticasone furoate—CYP3A4—Metabolism—CREBBP—lung cancer	4.03e-06	7.55e-05	CbGpPWpGaD
Fluticasone furoate—CYP3A4—Metabolism—PIK3CD—lung cancer	3.82e-06	7.16e-05	CbGpPWpGaD
Fluticasone furoate—CYP3A4—Metabolism—ALB—lung cancer	3.77e-06	7.06e-05	CbGpPWpGaD
Fluticasone furoate—CYP3A4—Metabolism—PIK3CB—lung cancer	3.33e-06	6.24e-05	CbGpPWpGaD
Fluticasone furoate—CYP3A4—Metabolism—PTGS2—lung cancer	3.3e-06	6.18e-05	CbGpPWpGaD
Fluticasone furoate—ABCB1—Metabolism—PIK3CA—lung cancer	3.29e-06	6.17e-05	CbGpPWpGaD
Fluticasone furoate—CYP3A4—Metabolism—PTEN—lung cancer	2.88e-06	5.39e-05	CbGpPWpGaD
Fluticasone furoate—CYP3A4—Metabolism—EP300—lung cancer	2.74e-06	5.14e-05	CbGpPWpGaD
Fluticasone furoate—ABCB1—Metabolism—AKT1—lung cancer	2.69e-06	5.04e-05	CbGpPWpGaD
Fluticasone furoate—CYP3A4—Metabolism—PIK3CA—lung cancer	2.03e-06	3.8e-05	CbGpPWpGaD
Fluticasone furoate—CYP3A4—Metabolism—AKT1—lung cancer	1.66e-06	3.11e-05	CbGpPWpGaD
